MSF Urges Wider Ervebo Use Against Bundibugyo as Kenya Reports One Patient Left in Care
Tuesday, November 10, 2026 · 6 min
Doctors Without Borders asks WHO's vaccine advisers to free Ervebo from research-only limits before their November 17 meeting, noting only 70,000 of 500,000 requested doses were released. Kenya's health minister says six patients have now recovered and one remains in treatment, edging the country toward its 42-day countdown.
Listen
Show notes
Doctors Without Borders asks WHO's vaccine advisers to free Ervebo from research-only limits before their November 17 meeting, noting only 70,000 of 500,000 requested doses were released. Kenya's health minister says six patients have now recovered and one remains in treatment, edging the country toward its 42-day countdown.
In this episode
- MSF DRC EBOLA: MSF calls for broader access to ERVEBO® vaccine during Bundibugyo Ebola outbreak — Médecins Sans Frontières UK
“In August, the DRC government, with support from Africa CDC, requested 500,000 doses of ERVEBO® from the World Health Organization's International Coordinating Group (ICG) on Vaccine Provision to support a broader vaccination strategy. Only 70,000 doses were released.”
- Kenya, WHO review Ebola response, strengthen cooperation – Kenya News Agency — KNA2
““Kenya has recorded nine cases linked to a single transmission cluster, with no evidence of community transmission. Six patients have recovered and been discharged, two have died and one remains under treatment,” reported Duale, adding that more than 772,000 travellers have been…”